CTI Biopharma (Formerly Cell Therapeutics)
CTI BioPharma | Seeking to Bring New Options to Patients with Blood Cancers.
Launch date
Employees
Market cap
AUD1.9b
Enterprise valuation
AUD1.8b (Public information from Jul 2023)
Share price
$9.09 CTIC
Seattle Washington (HQ)
Authorizing premium user...